Serum reactivity against bacterial pyruvate dehydrogenase: Increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis

Clinical and Developmental Immunology

Volumn 13, Issue 2-4, 2006, Pages 289-294

  Miyakawa, Hiroshi ^a   Tanaka, Atsushi ^a   Selmi, Carlo ^b   Hosoya, Naomi ^a   Mataki, Norikazu ^c   Kikuchi, Kentaro ^a,d   Kato, Takashi ^a   Arai, Junya ^a   Goto, Toshihiro ^a   Gershwin, M Eric ^d,e  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoantibodies; Cross reactivity; Escherichia coli; Specificity

Indexed keywords

BACTERIUM LYSATE; MITOCHONDRION ANTIBODY; MONOCLONAL ANTIBODY; PYRUVATE DEHYDROGENASE;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; AUTOANTIGENS; HUMANS; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIA; PYRUVATE DEHYDROGENASE COMPLEX;

EID: 33845676078     PISSN: 17402522     EISSN: 10292357     Source Type: Journal    
DOI: 10.1080/17402520600668706     Document Type: Article

References (23)

1. Alvarez F, Berg PA, et al. 1999. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929-938.
2. Coppel RL, McNeilage LJ, et al. 1988. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: Dihydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 85:7317-7321.
3. Dubel L, Tanaka A, et al. 1999. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology 29:1013-1018.
4. Eley MH, Namihira G, et al. 1972. Keto acid dehydrogenase complexes. 18. Subunit composition of the Escherichia coli pyruvate dehydrogenase complex. Arch Biochem Biophys 152:655-669.
5. Fussey SP, Ali ST, et al. 1990. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): Characterization of the main immunogenic region. Proc Natl Acad Sci USA 87:3987-3991.
6. Gershwin ME, Mackay IR, et al. 1987. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525-3531.
7. Gershwin ME, Selmi C, et al. 2005. Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients. Hepatology 42:1194-1202.
8. Kaisho T, Akira S. 2000. Critical roles of toll-like receptors in host defense. Crit Rev Immunol 20:393-405.
9. Kaisho T, Akira S. 2002. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 1589:1-13.
10. Kikuchi K, Lian ZX, et al. 2005. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 128:304-312.
11. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
12. Leung PS, Coppel RL, et al. 1997. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 17:61-69.
13. Migliaccio C, Nishio A, et al. 1998. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol 161:5157-5163.
14. Migliaccio C, Van de Water J, et al. 2001. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: The molecule versus the mimic. Hepatology 33:792-801.
15. Miyakawa H, Tanaka A, et al. 2001. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 34:243-248.
16. Moteki S, Leung PS, et al. 1996. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 24:97-103.
17. Selmi C, Balkwill DL, et al. 2003. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38:1250-1257.
18. Selmi C, Mayo MJ, et al. 2004. Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics and environment. Gastroenterology 127:485-492.
19. Talwalkar JA, Lindor KD. 2003. Primary biliary cirrhosis. Lancet 362:53-61.
20. Teoh KL, Mackay IR, et al. 1994. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: Implications for molecular mimicry. Hepatology 19:1029-1033.
21. Towbin H, Staehelin T, et al. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
22. Van de Water J, Ishibashi H, et al. 2001. Molecular mimicry and primary biliary cirrhosis: Premises not promises. Hepatology 33:771-775.
23. Wiesner RH, LaRusso NF, et al. 1985. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 88:108-114.